Sort
40,608 grants matching “prostate cancer”
GPR30 and hepatic cholesterol metabolism
$467,461David Q Wang · Albert Einstein College Of Medicine · R01 · FY2020 · DK
Tumor Detection and Classification using QUS Technology's Structure Function
$467,423William D. O'Brien · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$467,360Paul Mathew · Tufts Medical Center · R01 · FY2022 · CA
Delineate the Role of GSTP1 in Advanced Prostate Cancer
$467,334Tanya I Stoyanova · University Of California Los Angeles · R01 · FY2023 · CA
Cancer Nanotechnology in Imaging and Radiotherapy
$467,264Gayle E Woloschak · Northwestern University At Chicago · R25 · FY2011 · CA
Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
$467,258Xiaoqi Liu · University Of Kentucky · R01 · FY2021 · CA
PheWAS and GWAS of Telomere Length to Understand Human Disease
$467,221Scott Joseph Hebbring · Marshfield Clinic Research Foundation · R01 · FY2021 · GM
PROSTATE CANCER IN MEXICANS AMERICANS &AFRICAN AMERICAN
$467,204University Of Texas Md Anderson Can Ctr · R01 · FY2001 · CA
Biology of AR+ prostate cancer metastases and the role of the microenvironment
$467,174Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Quantitative histopathology for cancer prognosis using quantitative phase imaging on stained tissues
$467,172Mark A Anastasio · University Of Illinois At Urbana-Champaign · R01 · FY2023 · CA
NOVEL PROSTATE CANCER GENE AND MONOCLONAL ANTIBODY
$467,166Columbia University Health Sciences · R01 · FY2002 · CA
Resolving ensemble averaged conformations by multi-temperature x-ray crystallography
$467,162James Solomon Fraser · University Of California, San Francisco · R01 · FY2021 · GM
Structure and dynamics of clinically-relevant cytochrome P450 enzymes
$467,156Emily E Scott · University Of Michigan At Ann Arbor · R01 · FY2019 · GM
Role of Tumor Stem Cells Recurrent Prostate Cancer
$467,053Gary Smith · Univ Of North Carolina Chapel Hill · P01 · FY2011 · CA
Hybrid Plasma Markers that Complement CT Imaging for Early Lung Cancer Detection
$467,030Paul D Lampe · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA
Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance
$467,016Ping Mu · Yale University · R37 · FY2024 · CA
Use of Geographic Variations to Estimate Effectiveness with Non-Randomized Data
$467,006Mary Beth Landrum · Harvard Medical School · R01 · FY2012 · CA
COMBING CAR T CELLS WITH BLOCKADE OF TUMOR-INDUCED IMMUNOSUPPRESSION TO TARGET METASTATIC PROSTATE CANCER
$466,981Beckman Research Institute Of The City Of Hope · · FY2017 · Department of the Army
PSMA Antibody-Drug Conjugate for Prostate Cancer Therapy
$466,948Dangshe Ma · Progenics Pharmaceuticals, Inc. · R44 · FY2008 · CA
PROSTATE CANCER--FAMILY CARE FOR PATIENTS AND SPOUSES
$466,948University Of Michigan At Ann Arbor · R01 · FY2002 · CA
OHSU Center for Specialized Data Analysis as part of the GDAN
$466,877Paul T Spellman · Oregon Health & Science University · U24 · FY2019 · CA
Genetic Susceptibility And The Environment In Cancer Risk
$466,847Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Research Infrastructure Core
$466,815Valerie Odero-Marah · Clark Atlanta University · U54 · FY2021 · MD
IDENTIFICATION OF RECESSIVE PROSTATE CANCER RISK ALLELES IN THE MILLION VETERANS PROGRAM
$466,809Icahn School Of Medicine At Mount Sinai · · FY2025 · Defense Health Agency
miRNA Expression Profiling
$466,613David M Brown · Ambion Diagnostics, Inc. · R44 · FY2007 · CA